CLPT (ClearPoint Neuro, Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by CLPT officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-06 | Timothy T. Richards | Director | A | — | — |
| 2026-07-06 | R JOHN FLETCHER | Director | A | — | — |
| 2026-07-02 | JOSEPH BURNETT | CEO and President | A | — | — |
| 2026-07-02 | Danilo D'Alessandro | Chief Financial Officer | A | — | — |
| 2026-07-02 | L. JEREMY STIGALL | Chief Business Officer | A | — | — |
| 2026-07-01 | JOSEPH BURNETT | CEO and President | MIXED | — | — |
| 2026-06-22 | JOSEPH BURNETT | CEO and President | MIXED | — | — |
| 2026-06-08 | Timothy T. Richards | Director | MIXED | — | — |
| 2026-06-02 | Timothy T. Richards | Director | Sell | — | — |
| 2026-05-26 | LINDA M. LIAU | Director | A | — | — |
| 2026-05-26 | Timothy T. Richards | Director | A | — | — |
| 2026-05-26 | R JOHN FLETCHER | Director | A | — | — |
| 2026-05-26 | Matthew B. Klein | Director | Sell | — | — |
| 2026-05-26 | B KRISTINE JOHNSON | Director | A | — | — |
| 2026-05-26 | LYNNETTE C FALLON | Director | A | — | — |
| 2026-05-21 | Pascal E R Girin | Director | M | — | — |
| 2026-05-21 | LINDA M. LIAU | Director | M | — | — |
| 2026-05-21 | B KRISTINE JOHNSON | Director | M | — | — |
| 2026-05-21 | Matthew B. Klein | Director | M | — | — |
| 2026-05-21 | Timothy T. Richards | Director | M | — | — |
| 2026-05-21 | R JOHN FLETCHER | Director | M | — | — |
| 2026-05-21 | LYNNETTE C FALLON | Director | MIXED | — | — |
| 2026-04-02 | R JOHN FLETCHER | Director | A | — | — |
| 2026-04-02 | Timothy T. Richards | Director | A | — | — |
| 2026-04-02 | Pascal E R Girin | Director | A | — | — |
| 2026-03-20 | JOSEPH BURNETT | CEO and President | M | — | — |
| 2026-03-16 | MAZIN SABRA | Chief Operating Officer | MIXED | — | — |
| 2026-03-16 | Danilo D'Alessandro | Chief Financial Officer | MIXED | — | — |
| 2026-03-16 | L. JEREMY STIGALL | Chief Business Officer | MIXED | — | — |
| 2026-03-16 | JOSEPH BURNETT | CEO and President | MIXED | — | — |
| 2026-03-13 | Danilo D'Alessandro | Chief Financial Officer | MIXED | — | — |
| 2026-03-13 | L. JEREMY STIGALL | Chief Business Officer | MIXED | — | — |
| 2026-03-10 | MAZIN SABRA | Chief Operating Officer | MIXED | — | — |
| 2026-03-10 | L. JEREMY STIGALL | Chief Business Officer | MIXED | — | — |
| 2026-03-10 | Danilo D'Alessandro | Chief Financial Officer | MIXED | — | — |
| 2026-03-10 | JOSEPH BURNETT | CEO and President | MIXED | — | — |
| 2026-03-05 | JOSEPH BURNETT | CEO and President | MIXED | — | — |
| 2026-03-05 | Danilo D'Alessandro | Chief Financial Officer | MIXED | — | — |
| 2026-03-05 | L. JEREMY STIGALL | Chief Business Officer | MIXED | — | — |
| 2026-03-05 | MAZIN SABRA | Chief Operating Officer | MIXED | — | — |
| 2026-02-26 | JOSEPH BURNETT | CEO and President | Sell | — | — |
| 2026-02-19 | L. JEREMY STIGALL | Chief Business Officer | A | — | — |
| 2026-02-19 | Danilo D'Alessandro | Chief Financial Officer | A | — | — |
| 2026-02-19 | JOSEPH BURNETT | CEO and President | A | — | — |
| 2026-02-19 | MAZIN SABRA | Chief Operating Officer | A | — | — |
| 2026-01-27 | JOSEPH BURNETT | CEO and President | Sell | — | — |
| 2026-01-13 | JOSEPH BURNETT | CEO and President | MIXED | — | — |
| 2026-01-05 | Pascal E R Girin | Director | A | — | — |
| 2026-01-05 | R JOHN FLETCHER | Director | A | — | — |
| 2026-01-05 | MAZIN SABRA | Chief Operating Officer | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | CEO and President | 309,591 | — |
| — | Director | 131,011 | — |
| — | Director | 110,623 | — |
| — | Chief Business Officer | 110,263 | — |
| — | Chief Financial Officer | 103,769 | — |
| — | Director | 87,544 | — |
| — | Chief Operating Officer | 80,624 | — |
| — | Director | 71,116 | — |
| — | Chief Operating Officer | 68,739 | — |
| — | Director | 64,801 | — |
| — | Director | 53,318 | — |
| — | Director | 49,251 | — |
| — | Director | 46,935 | — |
| — | Chief Financial Officer | 36,331 | — |
| — | Director | 24,548 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the CLPT quote page; the site-wide leaderboard is on the insider transactions hub.